Clinical Trials Directory

Trials / Unknown

UnknownNCT05768152

Repeated Low-Level Red-Light Therapy Shortens Axial Length

Repeated Low-level Red-light Therapy in High Myopia Children and Teenagers: a Prospective Single-arm Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
The Second People's Hospital of Foshan · Academic / Other
Sex
All
Age
8 Years – 18 Years
Healthy volunteers
Accepted

Summary

The purpose of this clinical trial is to investigate the incidence and magnitude of axial length shortening after repeated low-level red-light therapy in high myopia children and teenagers.

Detailed description

High myopia has become a major public concern globally, which is characterized by excessive axial elongation of the eyeball. Axial elongation is accompanied by mechanical stretching and thinning of the choroid and sclera, causing vision-threatening complications. Repeated low-level red-light (RLRL) therapy is an emerging effective and safe therapy for myopia control. Previous clinical trials in China have observed clinically significant axial shortening after RLRL treatment. The purpose of this study is to investigate and identify possible mechanism for axial length (AL) shortening after 12-month RLRL therapy in highly myopic children and teenagers aged 8-18 years. In addition to single vision spectacles, subjects will receive RLRL treatment at home under supervision of the parents/guardians according to a standard protocol. Axial length, visual acuity, cycloplegic spherical equivalent refraction, slit lamp, fundus camera and optical coherence tomography/angiography will be measured at 1-, 3-, 6- and 12-month follow-up visits.

Conditions

Interventions

TypeNameDescription
DEVICERLRLRLRL will be performed twice per day with an interval of at least 4 hours, each treatment last 3 minutes, in addition to single vision spectacles with power for correcting distance refraction.

Timeline

Start date
2023-03-01
Primary completion
2024-05-01
Completion
2024-05-01
First posted
2023-03-14
Last updated
2023-03-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05768152. Inclusion in this directory is not an endorsement.